Try adjusting your type
14th October, 2009
European Survey on Standards of Care in paediatric oncology centres. J. R. Kowalczyk, M. Samardakiewicz, K. Pritchard-Jones, R. Ladenstein, S. Essiaf, E. Fitzgerald, G. Petrarulo, G. Vassal - EJC , Volume 61, pp 11-19
8th December, 2014
The purpose of this website is to provide good and clear information about the long-term effects of childhood cancer and to refer to the various late-effects outpatient clinics (LATER outpatient clinics) that exist in the Netherlands.
8th September, 2015
Cancer in young people is rare, but it is still a major health issue in Europe. Each year, more than 6,000 young people in Europe die of cancer. There are more than 300,000 European childhood cancer survivors (in 2020, they will be nearly half a million): two-thirds of them have some late side effects of treatment, that are severe and impact on the daily life of half of those affected.
Multiple myeloma is a type of blood cancer that originates from plasma cells, a type of white blood cell responsible for the production of antibodies. In this condition, these cells become malignant, multiply uncontrollably, and accumulate in the bone marrow, interfering with the production of healthy blood cells.
Multiple Myeloma is a complex medical condition affecting numerous individuals globally. A better understanding of this malady is not just crucial for the patients, but also adds value to the knowledge of those fortunate enough to be unaffected.
This article aims to provide a comprehensive review of Multiple Myeloma, its underlying causes, symptoms, the impact it has on the human body, and treatment options. Further, it maps out the lifestyle modifications necessary while living with this condition.
Multiple Myeloma is a form of cancer that develops in the plasma cells, a type of white blood cell created in the bone marrow. These cells are responsible for recognizing and combating infections. When cancerous, they multiply rapidly, overpopulating healthy cells and triggering complications.
The detrimental impact on the body varies. The overcrowded plasma cells disrupt the production of valuable antibodies, making the body vulnerable to infections. Additionally, these cells release harmful substances that damage the kidneys and affect bone strength.
Compared to other forms of cancer, Multiple Myeloma is relatively rare, accounting for about 1% of all cancers. Despite its rarity, the impact can be severe, revealing the necessity for increased focus on this disease.
The symptoms of Multiple Myeloma are relatively ambiguous and often confused with common health issues. Frequent indicators include severe fatigue, inexplicable bone pain, particularly in the spine or chest, frequent infections, and unexplained weight loss.
Medical professionals diagnose multiple myeloma symptoms through various tests, such as blood and urine tests, bone marrow aspirations and biopsies, imaging tests, and genetic testing.
The primary cause of multiple myeloma remains unknown. However, it appears to initiate with an abnormal change in the DNA of a single plasma cell, making it cancerous. Over time, this cell multiplies, creating more abnormal cells that accumulate in the bone marrow, leading to myeloma.
Several factors increase the risk of Multiple Myeloma, including age (most common in older adults), male gender, African American race, a history of monoclonal gammopathy, and exposure to radiation or certain chemicals.
Multiple Myeloma treatment often includes chemotherapy, targeted therapy, biologic therapy, and corticosteroids. In severe cases, stem cell transplants may be necessary. Factors such as age, overall health, symptoms, and the extent of the disease determine the treatment protocol.
Emerging treatments and technologies show promise in their ability to target cells more specifically and reduce side effects. Immune therapy and CAR-T cell treatment are among these growing trends.
The lifestyle modifications demanded by Multiple Myeloma diagnosis are significant. Adequate hydration, regular exercise, a balanced diet, and proper rest, are crucial steps towards managing this condition.
A wealth of support is available for patients, from medical teams and therapists to patient supportive communities and family members. These networks offer indispensable help in terms of the emotional, psychological, and logistical challenges posed by the disease.
Recognizing and understanding Multiple Myeloma effectively, unlocking its underlying causes, symptoms, and treatment options are pivotal steps towards controlling its impact.
It’s crucial to remember that despite a Multiple Myeloma diagnosis, life can continue with certain modifications. The support from healthcare professionals, family, friends, and a determined spirit can equip individuals to handle this unexpected journey.
Multiple Myeloma is a type of cancer that starts in the plasma cells present in the bone marrow. It constitutes about 1% of all cancers.
Common symptoms include fatigue, bone pain, frequent infections, and unexplained weight loss.
An abnormality in the DNA of a plasma cell, causing it to become cancerous, is believed to trigger Multiple Myeloma.
Options vary, including chemotherapy, targeted therapy, biologic therapy, corticosteroids, and possibly stem cell transplants.
Living with Multiple Myeloma requires lifestyle modifications such as adequate hydration, a balanced diet, and proper rest. Emotional and psychological support is also crucial.
Share it
You might also like
Tuesdays with Morrie: An Old Man, a Young Man, and Life’s Greatest Lesson
Maybe it was a grandparent, or a teacher, or a colleague. Someone older, patient and wise, who understood you when you were young and searching, helped you see the world as a more profound place, gave you sound advice to help you make your way through it.
Option B: Facing Adversity, Building Resilience, and Finding Joy
In 2015 Sheryl Sandberg’s husband, Dave Goldberg, died suddenly at the age of forty-eight. Sandberg and her two young children were devastated, and she was certain that their lives would never have real joy or meaning again.
Dying to Be Me: My Journey from Cancer, to Near Death, to True Healing
Anita Moorjani's memoir, "Dying to Be Me," is a deeply inspiring account of her extraordinary journey through illness, near-death, and profound self-discovery.
It’s Not About the Bike: My Journey Back to Life
"It's Not About the Bike," co-authored by Lance Armstrong and Sally Jenkins, is a gripping memoir that chronicles Armstrong's journey from a cancer diagnosis with low survival odds to his astonishing comeback and victory in the 1999 Tour de France. This inspiring tale is a testament to the resilience of the human spirit and the power of determination to overcome life's greatest challenges.
The Cancer-Fighting Kitchen: Nourishing, Big-Flavor Recipes for Cancer Treatment and Recovery
This new and revised edition of the IACP award-winning cookbook brings the healing power of delicious, nutritious foods to those whose hearts and bodies crave a revitalizing meal, through 150 new and updated recipes.
The Emperor of All Maladies: A Biography of Cancer
An award-winning exploration of cancer's intricate history and humanity's relentless fight against it. From ancient origins to modern breakthroughs, Siddhartha Mukherjee's Pulitzer Prize-winning book reveals the captivating, inspiring, and sometimes sobering tale of 'The Emperor of All Maladies.'
When Randy Pausch, a computer science professor at Carnegie Mellon, was asked to give such a lecture, he didnt have to imagine it as his last, since he had recently been diagnosed with terminal cancer. But the lecture he gave, Really Achieving Your Childhood Dreams, wasnt about dying.
